<HTML>
<HEAD>
   <TITLE>k072120082.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">


<A name="page_1"></A>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><FONT face=serif size=2>UNITED STATES</FONT><BR>
<FONT face=serif size=2>SECURITIES AND EXCHANGE COMMISSION</FONT><BR>
<FONT face=serif size=2>WASHINGTON, DC 20549</FONT></TD></TR></TABLE></P>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><B><FONT face=serif size=5>FORM 8-K</FONT></B><BR>
<B><FONT face=serif size=2>CURRENT REPORT</FONT></B></TD></TR></TABLE></P>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><B><FONT face=serif size=2>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</FONT></B></TD></TR></TABLE></P>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><FONT face=serif size=2>Date of report (Date of earliest event reported: July 21, 2008)</FONT></TD></TR></TABLE></P>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><B><FONT face=serif size=5>Innophos, Inc.</FONT></B><BR>
<B><FONT face=serif size=5>Innophos Holdings, Inc.</FONT></B></TD></TR></TABLE></P>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><FONT face=serif size=2>(EXACT NAMES OF REGISTRANTS AS SPECIFIED IN THEIR CHARTERS)</FONT></TD></TR></TABLE></P>
<DIV align=center>
<TABLE cellSpacing=0 cellPadding=0 border=0>
<TR>
     <TD width="35%"></TD>
     <TD width="3%"></TD>
     <TD width="36%"></TD>
     <TD width="25%"></TD></TR>
<TR vAlign=bottom>
     <TD align=center><B><FONT face=serif size=1>Delaware</FONT></B>&nbsp; </TD>
     <TD align=right>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=1>333-129951</FONT></B>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=1>20-1380712</FONT></B>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center><B><FONT face=serif size=1>Delaware</FONT></B>&nbsp; </TD>
     <TD align=right>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=1>001-33124</FONT></B>&nbsp; </TD>
     <TD align=center><B><FONT face=serif size=1>20-1380758</FONT></B>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center><FONT face=serif size=1>(States or other jurisdictions of incorporation)</FONT>&nbsp; </TD>
     <TD align=right>&nbsp; </TD>
     <TD align=center><FONT face=serif size=1>(Commission File Numbers)</FONT>&nbsp; </TD>
     <TD align=center><FONT face=serif size=1>(IRS Employer Identification Nos.)</FONT>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4 rowSpan=2><B><FONT face=serif size=1>259 Prospect Plains Road</FONT></B><BR>
<B><FONT face=serif size=1>Cranbury, New Jersey 08512</FONT></B></TD></TR>
<TR vAlign=bottom></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4><FONT face=serif size=1>(Address of Principal Executive Offices, including Zip Code)</FONT></TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4><B><FONT face=serif size=1>(609)</FONT></B> <B><FONT face=serif size=1>495-2495</FONT></B></TD></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4><FONT face=serif size=1>(Registrants&#146; Telephone Number, Including Area Code)</FONT></TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR>
     <TD colSpan=4>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4><B><FONT face=serif size=2>Not Applicable</FONT></B></TD></TR>
<TR vAlign=bottom>
     <TD align=center colSpan=4><FONT face=serif size=2>(Former name or former address, if changed since last report)</FONT>&nbsp; </TD></TR>
<TR>
     <TD align=center colSpan=4></TD></TR></TABLE></DIV>
<P>&nbsp;</P>
<P align=left>
<TABLE>
<TR>
     <TD noWrap>
<P><FONT face=serif size=2>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of</FONT><BR>
<FONT face=serif size=2>the registrant under any of the following provisions:</FONT></P>
<P><FONT size=2></FONT><BR>
<FONT face=serif size=2>[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT><BR>
<FONT face=serif size=2>[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)</FONT><BR>
<FONT face=serif size=2>[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</FONT><BR>
<FONT face=serif size=2>[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</FONT></P>
</TD></TR></TABLE></P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>


<A name="page_2"></A>
<P align=left><B><FONT face=serif size=2>Item 1.01 Entry into a Material Definitive Agreement.</FONT></B></P>
<P align=left><FONT face=serif size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT face=serif size=2>On June 5, 2002, the Registrants&#146; subsidiary, Innophos Fosfatados de Mexico S.A. de C.V. (f/k/a Rhodia Fosfatados de Mexico S.A. de C.V.), entered into an addendum to a phosphate rock supply agreement dated September 10, 1992 with Office Cherifien Des Phosphates, or the OCP Agreement. The addendum extended the initial term of the OCP Agreement by three years to expire September 9, 2010, subject thereafter to automatic extensions of five years each, with each extension subject to not less than one year&#146;s prior written notice of termination by either party, as more fully described in the OCP Agreement.</FONT></P>
<P align=left><FONT face=serif size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT face=serif size=2>A copy of the OCP Agreement prior to the addendum referred to above was included as Exhibit No. 12 to the Registration Statement on Form S-4 of Innophos, Inc. filed on February 14, 2006 (File No. 333-129951). The effect of the addendum was described in the prospectus forming part of the 2006 registration statement, but, inadvertently, the addendum itself was not filed as an exhibit to that registration statement. A copy of the addendum (in redacted form subject to a confidential treatment request being submitted to the Securities and Exchange Commission) is now being filed as Exhibit 99.1 to this Current Report on Form 8-K.</FONT></P>
<P align=left><B><FONT face=serif>Item 9.01 Exhibits</FONT></B><BR>
<BR>
<B><FONT face=serif>(b) Exhibits</FONT></B></P>
<P align=left>
<TABLE style="WIDTH: 742px; HEIGHT: 96px" cellSpacing=0 cellPadding=0 border=0>
<TR>
     <TD width="21%"></TD>
     <TD width="78%"></TD></TR>
<TR>
     <TD colSpan=2></TD></TR>
<TR vAlign=bottom>
     <TD noWrap align=left><U><FONT face=serif>Exhibit No.</FONT></U><FONT face=serif>&nbsp; </FONT></TD>
     <TD noWrap align=left><U><FONT face=serif>Description</FONT></U><FONT face=serif></FONT> <FONT face=serif></FONT></TD></TR>
<TR vAlign=bottom>
     <TD noWrap align=left><FONT face=serif>99</FONT><FONT face=serif>&nbsp; </FONT></TD>
     <TD noWrap align=left><FONT face=serif>&nbsp; Addendum # 7 to OCP Agreement*</FONT></TD></TR></TABLE></P>
<P><FONT face=serif size=2>*CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. </FONT></P>
<P></P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>
<P></P>


<A name="page_3"></A>
<P align=center>
<TABLE>
<TR>
     <TD noWrap align=center><B><FONT face=serif size=2>SIGNATURES</FONT></B></TD></TR></TABLE></P>
<P align=left><FONT size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT face=serif size=2>According to the requirements of the Securities Exchange Act of 1934, the Registrants have duly caused this report to be signed on their behalf by the undersigned, hereunto duly authorized.</FONT></P>
<TABLE style="WIDTH: 1136px; HEIGHT: 170px" cellSpacing=0 cellPadding=0 border=0>
<TR>
     <TD width="36%"></TD>
     <TD width="63%"></TD></TR>
<TR vAlign=bottom>
     <TD align=left><FONT size=2>&nbsp; </FONT></TD>
     <TD align=left><B><FONT face=serif size=2>INNOPHOS, INC.</FONT></B><FONT size=2>&nbsp; </FONT></TD></TR>
<TR vAlign=bottom>
     <TD align=left><FONT size=2>&nbsp; </FONT></TD>
     <TD align=left><B><FONT face=serif size=2>INNOPHOS HOLDINGS, INC.</FONT></B><FONT size=2>&nbsp; </FONT></TD></TR>
<TR>
     <TD colSpan=2><FONT size=2>&nbsp; </FONT></TD></TR>
<TR>
     <TD colSpan=2><FONT size=2>&nbsp; </FONT></TD></TR>
<TR vAlign=bottom>
     <TD align=left><FONT size=2>&nbsp; </FONT></TD>
     <TD align=left><FONT face=serif size=2>By:</FONT><FONT size=2>&nbsp; _____________________________________</FONT></TD></TR>
<TR vAlign=bottom>
     <TD align=left><FONT face=serif size=2>Date: July 21, 2008</FONT><FONT size=2>&nbsp; </FONT></TD>
     <TD align=left><FONT face=serif size=2>Name: Richard Heyse</FONT><FONT size=2>&nbsp; </FONT></TD></TR>
<TR vAlign=bottom>
     <TD align=left><FONT size=2>&nbsp; </FONT></TD>
     <TD align=left><FONT face=serif size=2>Title: Vice President &amp; Chief Financial Offcier</FONT><FONT size=2>&nbsp; </FONT></TD></TR></TABLE><BR>
<P align=left>&nbsp;</P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "k072120082.htm", "secsgml_size_bytes": 9374}]
{"company-data": {"conformed-name": "Innophos Holdings, Inc.", "cik": "0001364099", "assigned-sic": "5160", "irs-number": "201380758", "fiscal-year-end": "1207"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33124", "film-number": "08961576"}, "business-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512", "phone": "(609) 495 2495"}, "mail-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512"}}
k072120082.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported: July 21, 2008)
Innophos, Inc.
Innophos Holdings, Inc.
(EXACT NAMES OF REGISTRANTS AS SPECIFIED IN THEIR CHARTERS)
Delaware
333-129951
20-1380712
Delaware
001-33124
20-1380758
(States or other jurisdictions of incorporation)
(Commission File Numbers)
(IRS Employer Identification Nos.)
259 Prospect Plains Road
Cranbury, New Jersey 08512
(Address of Principal Executive Offices, including Zip Code)
(609)
495-2495
(Registrants' Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On June 5, 2002, the Registrants' subsidiary, Innophos Fosfatados de Mexico S.A. de C.V. (f/k/a Rhodia Fosfatados de Mexico S.A. de C.V.), entered into an addendum to a phosphate rock supply agreement dated September 10, 1992 with Office Cherifien Des Phosphates, or the OCP Agreement. The addendum extended the initial term of the OCP Agreement by three years to expire September 9, 2010, subject thereafter to automatic extensions of five years each, with each extension subject to not less than one year's prior written notice of termination by either party, as more fully described in the OCP Agreement.
A copy of the OCP Agreement prior to the addendum referred to above was included as Exhibit No. 12 to the Registration Statement on Form S-4 of Innophos, Inc. filed on February 14, 2006 (File No. 333-129951). The effect of the addendum was described in the prospectus forming part of the 2006 registration statement, but, inadvertently, the addendum itself was not filed as an exhibit to that registration statement. A copy of the addendum (in redacted form subject to a confidential treatment request being submitted to the Securities and Exchange Commission) is now being filed as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Exhibits
(b) Exhibits
Exhibit No.
Description
99
Addendum # 7 to OCP Agreement*
*CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
SIGNATURES
According to the requirements of the Securities Exchange Act of 1934, the Registrants have duly caused this report to be signed on their behalf by the undersigned, hereunto duly authorized.
INNOPHOS, INC.
INNOPHOS HOLDINGS, INC.
By:
_____________________________________
Date: July 21, 2008
Name: Richard Heyse
Title: Vice President & Chief Financial Offcier